Immunology

Study tracks COVID-19 antibodies over time

The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health. The study also finds that older recipients ...

Oncology & Cancer

Fourth SARS-CoV-2 vaccination also protects cancer patients

A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports ...

HIV & AIDS

Three-dose hepatitis B vaccine regimen protects people with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B has fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented ...

Diseases, Conditions, Syndromes

Death toll rises as flu epidemic grips US

The death toll from a flu outbreak gripping the United States has reached epidemic levels and it will be at least several weeks before the outbreak abates, health officials said Friday.

Vaccination

AstraZeneca says booster jab effective against Omicron

British pharmaceutical giant AstraZeneca said Thursday that a third, or "booster", dose of its COVID-19 vaccine Vaxzevria "significantly" lifted antibody levels against the Omicron strain in a laboratory study.

page 7 from 15